Top Stories
Duke’s biobanks will give Network Bio access to patient samples linked to years of clinical records, helping train AI models for drug discovery and disease detection.
Eli Lilly's two GLP-1 offerings Zepbound (tirzepatide) and Foundayo (orforglipron) will be available via Hims & Hers' consumer platform.
Researchers developed an AI system that uses smartwatch sensors to passively detect hypertension, without cuff calibration.
The deal adds to the Swiss drugmaker's growing AI push, which includes plans for autonomous R&D labs and a search for a global head of AI for drug discovery.
More than 20,000 patients with persistent bloating or abdominal discomfort will take part in the trial to see whether blood tests can help doctors determine who needs urgent cancer investigations.
Conference News
American Heart Association Resuscitation Science Symposium 2026, Late-Breaking Science Abstract Or03Research Highlights:Selecting which volunteer community first responders were alerted to the scene o...
American Heart Association Resuscitation Science Symposium 2026, Late-Breaking Science Abstract Or05Research Highlights:Alerting nearby CPR-trained volunteers through a smartphone app did not increase...
Plaque-guided care improved diagnostic certainty and increased use of preventive therapy compared with usual care in patients with suspected coronary artery diseaseDENVER--(BUSINESS WIRE)-- Cleerly, a...
Second poster at ACR Convergence 2026 shows PRIMA-102 study participants are broadly representative of routine care, supporting clinical validation and clinical utility effortsHAYWARD, Calif. & ORLAND...
CyPath® Lung test unit sales double year to date over 2025, with solid gains in physician utilization and recurring orders; testing revenue increases 79% year-to-dateCompany advances precision medicin...
